Roger Newton - co-discoverer of Liptor, the world's top selling drug and CEO of Ann Arbor area biotech firm Esperion Therapeutics - discusses Esperion's progress and the company's chief goal: commercializing a drug therapy to help increase "good" HDL cholesterol. This video was produced by Nathan Bomey for AnnArbor.com.
Link to this comment:
All Comments (0)